Modulation of the Inflammatory Response by Human Immunoglobulin A

  • M. M. Eibl
  • H. M. Wolf
Conference paper


The mucosal surfaces constitute large areas in direct contact with the environment and are therefore especially vulnerable to infections. Both specific and nonspecific (e.g., lactoferrin, lysozyme, and other enzymes) host defense mechanisms are involved in the protection of the mucosal surfaces against infection with potentially pathogenic microorganisms. Antibodies produced locally by cells of the mucosal immune system are an important component of immune defense at these sites.


Respiratory Burst Human Immunoglobulin Bovine Colostrum Reactive Oxygen Radical Human Serum Immunoglobulin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adachi M, Yodoi J, Masuda T, Takatsuki K, Uchino H (1983) Altered expression of lymphocyte Fea receptor in selective IgA deficiency and IgA nephropathy. J Immunol 131: 1246–1251PubMedGoogle Scholar
  2. Beebe DP, Schreiber RD, Cooper NR (1983) Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement. J Immunol 130: 1317–1322PubMedGoogle Scholar
  3. Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379–385PubMedGoogle Scholar
  4. Beutler B, Milsark IW, Cerami A (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869–871PubMedGoogle Scholar
  5. Brandtzaeg P (1992) Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J Infect Dis 165 [Suppl 1]: S167–176PubMedGoogle Scholar
  6. Caplan MS, Hsueh W (1990) Necrotizing entrocolitis: role of platelet activating factor, endotoxin and tumor necrosis factor. J Pediatr 117 [Suppl 1, part 2]: S47–S51PubMedGoogle Scholar
  7. Clark DA, Fornabaio DM, McNeill H, Mullane KM, Caravella SJ, Miller MJ (1988) Contribution of oxygen–derived free radicals to experimental necrotizing enterocolitis. Am J Pathol 130: 537–542PubMedGoogle Scholar
  8. Caplan MS, Sun X-M, Hsueh W, Hageman JR (1990) Role of platelet activating factor and tumor necrosis factor–alpha in neonatal necrotizing enterocolitis. J Pediatr 116: 960–964PubMedGoogle Scholar
  9. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activa–tion of calcium–activated, phospholipid–dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851PubMedGoogle Scholar
  10. Clemens JB, Stanton B, Stoll B, Shahid NS, Banu H, Chowdhury AJMA (1986) Breastfeeding as a determinant of severity in shigellosis: evidence for protection throughout the first three years of life in Bangladeshi children. Am J Epidemiol 123: 710–720PubMedGoogle Scholar
  11. Duffy LC, Riepenhoff–Talty M, Byers TE, La Scolea LJ, Zielezny MA, Dryja DM, Ogra PL (1986) Modulation of rotavirus enteritis during breastfeeding. Am J Dis Child 140: 1164–1168Google Scholar
  12. Egido J, Sancho J, Lorente F, Fontan G (1982) Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy. Clin Exp Immunol 49: 709–716PubMedGoogle Scholar
  13. Eibl MM, Wolf HM, Fiirnkranz H, Rosenkranz A (1988) Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA–IgG feeding. N Engl J Med 319: 1–7PubMedGoogle Scholar
  14. Endoh M, Sakai H, Nomoto Y, Tomino Y, Kaneshige H (1981) IgA–specific helper activity of Ta cells in human peripheral blood. J Immunol 127: 2612–2613PubMedGoogle Scholar
  15. Ferreri NR, Howland WC, Spiegelberg HL (1986) Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. J Immunol 136: 4188–4193Google Scholar
  16. Fubara ES, Freter R (1973) Protection against enteric bacterial infection by secretory IgA antibodies. J Immunol 111: 395–403PubMedGoogle Scholar
  17. Glass RI, Svennerholm A–M, Stoll BJ, Khan MR, Belayet Hossain KM, Imadul Huq M, Holmgren J (1983) Protection against cholera in breast–fed children by antibodies in breast milk. N Engl J Med 308: 1389–1392PubMedGoogle Scholar
  18. Gothefors L, Oiling S, Winberg J (1975) Breast feeding and biological properties of fecal E. coli strains. Acta Paediatr Scand 64: 807–812Google Scholar
  19. Griffiss JM (1975) Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol 114: 1779–1784PubMedGoogle Scholar
  20. Griffiss JM, Goroff DK (1983) IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J Immunol 130: 2882–2885PubMedGoogle Scholar
  21. Gupta S, Platsoucas CD, Schulof RS, Good RA (1979) Receptors for IgA on a subpopulation of human T and B lymphocytes. Cell Immunol 45: 469–470PubMedGoogle Scholar
  22. Hammarstrom V, Smith CIE, Hammarstrom L (1993) Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 341: 1036PubMedGoogle Scholar
  23. Hayani KC, Guerrero ML, Morrow AL, Gomez HF, Winsor DK, Ruiz-Palarios GM, Cleary TG (1992) Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breastfed infants. J Pediatr 121: 852–856PubMedGoogle Scholar
  24. Henson PM, Johnston RB Jr (1987) Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 79: 669–674PubMedGoogle Scholar
  25. Hiemstra PS, Gorter A, Stuurman ME, van Es LA, Daha MR (1987) Activation of the alternative pathway of complement by human serum Ig A. Eur J Immunol 17: 321–326PubMedGoogle Scholar
  26. Hiemstra PS, Biewenga J, Gorter A, Stuurman ME, Faber A, van Es LA, Daha MR (1988) Activation of complement by human serum Ig A, secretory Ig A and IgAl fragments. Mol Immunol 25: 527–533PubMedGoogle Scholar
  27. Hilpert H, Brussow H, Mietens C, Sidoti J, Lerner L, Werchau H (1987) Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 156: 158–166PubMedGoogle Scholar
  28. Hoover RG, Lynch RG (1980) Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with Ig A plasmacytomas. J Immunol 125: 1280–1285Google Scholar
  29. Hoover RG, Lynch RG (1983) Isotype-specific suppression of Ig A: suppression of Ig A responses in BALB/c mice by Ta cells. J Immunol 130: 521–523PubMedGoogle Scholar
  30. Hoover RG, Hickman S, Gebel HM, Rebbe N, Lynch RG (1981) Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma. J Clin Invest 67: 308–311PubMedGoogle Scholar
  31. Hoover RG, Dieckgraefe BK, Lake J, Kemp JD, Lynch RG (1982) Lymphocyte surface membrane immunoglobulin in myeloma. III. Ig A plasmacytomas induce large numbers of circulating, adult–thymectomy–sensitive, 0+ Lyt-l-2+ lymphocytes with IgA-Fc receptors. J Immunol 129: 2329–2331PubMedGoogle Scholar
  32. Ito S, Mikawa H, Shinomiya K, Yoshida T (1979) Suppressive effect of Ig A soluble immune complexes on neutrophil Chemotaxis. Clin Exp Immunol 37: 436–440PubMedGoogle Scholar
  33. Jarvis GA, Griffiss JM (1991) Human IgAl blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen–binding fragment binding to the polysaccharide capsule. J Immunol 147: 1962–1967PubMedGoogle Scholar
  34. Joiner KA (1985) Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody. In: Compans RW, Cooper M, Koprowski H et al. (eds) Current topics in microbiology and immunology, vol 121. Springer, Berlin Heidelberg New York, pp 99–133Google Scholar
  35. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME (1991) The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for Ig A. Proc Natl Acad Sei USA 88: 8796–8800Google Scholar
  36. Kelly CP, Pothoulakis C, Orellana J, LaMont JT (1992) Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 102: 35–40PubMedGoogle Scholar
  37. Kemp AS, Cripps AW, Brown S (1980) Suppression of leukocyte chemokinesis and Chemotaxis by human Ig A. Clin Exp Immunol 40: 388–395PubMedGoogle Scholar
  38. Kerr MA (1990) The structure and function of human IgA. Biochem J 271: 285–296PubMedGoogle Scholar
  39. Kiyono H, McGhee JR, Mosteller LM, Eldridge JH, Koopman WJ, Kearney JF, Michalek SM (1982) Murine Peyer’s patch T–cell clones: characterization of antigen-specific helper T cells for immunoglobulin A responses. J Exp Med 156: 1115–1130PubMedGoogle Scholar
  40. Kiyono H, Cooper MD, Kearney JF, Mosteller LM, Michalek SM, Koopman WJ, McGhee JR (1984a) Isotype–specificity of helper T cell clones. Peyer’s patch 111 cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med 159: 798–811PubMedGoogle Scholar
  41. Kiyono H, Phillips JO, Colwell DE, Michalek SM, Koopman WJ, McGhee JR (1984b) Isotype-specificity of helper T cell clones: Fca receptors regulate T-cell and B-cell collaboration for IgA responses. J Immunol 133: 1087–1089Google Scholar
  42. Lehmann V, Freudenberg MA, Galanos C (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D–galactosamine–treated mice. J Exp med 165: 657–663PubMedGoogle Scholar
  43. Losonsky GA, Johnson JP, Winkelstein J A, Yolken RH (1985) Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis: a pharmacokinetic and functional analysis. J Clin Invest 76: 2362–2367PubMedGoogle Scholar
  44. Lucisano Valim YM, Lachmann PJ (1991) The effect of antibody isotype and antigenic epitope density on the complement–fixing activity of immune complexes: a systematic study using chimaeric anti–NIP antibodies with human Fc regions. Clin Exp Immunol 84: 1–8PubMedGoogle Scholar
  45. Lum LG, Muchmore AV, Keren D, Decker J, Koski I, Strober W, Blaese RM (1979) AGoogle Scholar
  46. receptor for IgA on human T lymphocytes. J Immunol 122:65–69Google Scholar
  47. Lydyard PM, Fanger MW (1981) Receptors for IgA on human lymphocytes. II. Organ distribution and relationships with other Fc receptor–bearing populations. Scand J Immunol 14: 509–514Google Scholar
  48. Malech HL, Gallin JI (1987) Neutrophils in human diseases. N Engl J Med 317: 687–694PubMedGoogle Scholar
  49. Maliszewski CR, Shen L, Fanger MW (1985) The expression of receptors for IgA on human monocytes and calcitriol–treated HL–60 cells. J Immunol 135: 3878–3881PubMedGoogle Scholar
  50. Mata LJ, Urrutia JJ, Garcia B, Fernández R, Behar M (1969) Shigella infection in breastfed Guatemalan Indian neonates. Am J Dis Child 117: 142–146PubMedGoogle Scholar
  51. Mathison JC, Wolfson E, Ulevitch RJ (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81: 1925–1937PubMedGoogle Scholar
  52. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89: 6901–6905PubMedGoogle Scholar
  53. McGhee JR, Mestecky J, Elson CO, Kiyono H (1989) Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 9: 175–199PubMedGoogle Scholar
  54. Mestecky J, McGhee JR (1987) Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40: 153–245PubMedGoogle Scholar
  55. Mietens C, Keinhorst H, Hilpert H, Gerber H, Amster H, Pahud JJ (1979) Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. Eur J Pediatr 132: 239–252Google Scholar
  56. Miller MJ, McNeill H, Mullane KM, Caravella SJ, Clark DA (1988) SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. Am J Physiol 255: G556–G565PubMedGoogle Scholar
  57. Morel F, Doussiere J, Vignais PV (1991) The superoxide-generating oxidase of phagocytic cells. Physiological molecular and pathological aspects. Eur J Biochem 201: 523–546Google Scholar
  58. Noro N, Adachi M, Yasuda K, Masuda T, Yodoi J (1986) Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA–BF. J Immunol 136: 2910–2916PubMedGoogle Scholar
  59. Ogra PL, Karzon DT (1969) Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol 102: 1423–1430PubMedGoogle Scholar
  60. Ourth DD (1974) Neutralization of diphteria toxin by human immunoglobulin classes and subclasses. Immunochemistry 11: 223–225PubMedGoogle Scholar
  61. Perkins JC, Tucker DN, Knope HLS, Wenzel RP, Hornick RB, Kapikian AZ, Chanock RM (1969) Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol 90: 319–326PubMedGoogle Scholar
  62. Reed WP (1975) Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils. Immunology 28: 1051–1059PubMedGoogle Scholar
  63. Robinson G, Volovitz B, Passwell JH (1991) Identification of a secretory IgA receptor on breast-milk macrophages: evidence for specific activation via these receptors. Pediatr Res 29: 429–434PubMedGoogle Scholar
  64. Russel MW, Reinholdt J, Kilian M (1989) Anti–inflammatory activity of human IgA anti-bodies and their Faba fragments: inhibition of IgG–mediated complement activation. Eur J Immunol 19: 2243–2249Google Scholar
  65. Russell-Jones GJ, Ey PL, Reynolds BL (1980) The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody. Mol Immunol 17: 1173–1180PubMedGoogle Scholar
  66. Russell-Jones GJ, Ey PL, Reynolds BL (1981) Inhibition of cutaneous anaphylaxis and Arthus reactions in the mouse by antigen-specific Ig A. Int Arch Allergy Appl Immunol 66: 316–325PubMedGoogle Scholar
  67. Sabin AB, Fieldsteel AH (1962) Antipoliomyelitic activity of human and bovine colostrum and milk. Pediatrics 29: 105–115PubMedGoogle Scholar
  68. Saito K, Kato C, Katsuragi H, Komatsuzaki A (1991) IgA-mediated inhibition of human leukocyte function by interference with Fcx and C3b receptors. Immunology 74: 99–106PubMedGoogle Scholar
  69. Sandor M, Ibraghimov A, Rosenberg MG, Teeraratkul P, Lynch RG (1992). Expression of IgA and IgM Fc receptors on murine T lymphocytes. Immunol Res 11: 169–180PubMedGoogle Scholar
  70. Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD (1991) IgA deficiency. Immunodefic Rev 3: 15–44Google Scholar
  71. Shen L (1992a) Receptors for IgA on phagocytic cells. Immunol Res 11: 273–282PubMedGoogle Scholar
  72. Shen L (1992b) A monoclonal antibody specific for immunoglobulin A receptor triggers polymorphonuclear neutrophil superoxide release. J Leukoc Biol 51: 373–378PubMedGoogle Scholar
  73. Shen L, Collins J (1989) Monocyte superoxide secretion triggered by human IgA. Immunology 68: 491–496PubMedGoogle Scholar
  74. Shen L, Fanger MW (1981) Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes. Immunology 59: 75–81Google Scholar
  75. Shen L, Maliszewski CR, Rigby WF, Fanger MW (1986) IgA–mediated effector function ofGoogle Scholar
  76. HL-60 cells following treatment with calcitriol. Mol Immunol 23:611–618Google Scholar
  77. Shen L, Lasser R, Fanger MW (1989) My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J Immunol 143: 4117–4122PubMedGoogle Scholar
  78. Sibille Y, Delacroix DL, Merill WW, Chatelain B, Vaerman JP (1987) IgA-induced chemo-kinesis of human polymorphonuclear neutrophils: requirement of their Fc-alpha receptor. Mol Immunol 24: 551–559PubMedGoogle Scholar
  79. Sjoberg O (1980) Presence of receptors for IgA on human T and non–T lymphocytes. Eur J Immunol 10: 226–228PubMedGoogle Scholar
  80. Sun X, Hsueh W (1988) Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet–activating factor. J Clin Invest 81: 1328–1331PubMedGoogle Scholar
  81. Tacket CO, Losonsky G, Link H, Hoang Y, Guesry P, Hilpert H, Levine MM (1988) Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 318: 1240–1243PubMedGoogle Scholar
  82. Taylor HP, Dimmock NJ (1985) Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med 161: 198–209PubMedGoogle Scholar
  83. Tjellström B, Stenhammar L, Eriksson S, Magnusson KE (1993) Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet 431: 701–702Google Scholar
  84. Tomasi TB, Tan EM, Solomon A, Prendergast RA (1965) Characteristics of an immune system common to certain external secretions. J Exp Med 121: 101–124PubMedGoogle Scholar
  85. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wölpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470–474PubMedGoogle Scholar
  86. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti–cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.5 Nature 330: 662–664Google Scholar
  87. Tramont EC (1977) Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest 59: 117–124PubMedGoogle Scholar
  88. Trush MA, Wilson ME, Van Dyke K (1978) The generation of chemiluminescence ( CL) by phagocytic cells. Methods Enzymol 57: 462–494Google Scholar
  89. Turner RB, Kelsey DK (1993) Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 12: 718–722PubMedGoogle Scholar
  90. Tzipori S, Roberton D, Chapman C (1986) Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J 293: 1276–1277Google Scholar
  91. Van Epps DE, Brown SL (1981) Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins. Infect Immun 34: 864–870PubMedGoogle Scholar
  92. Van Epps DE, Williams RC (1976) Suppression of leukocyte Chemotaxis by human Ig A myeloma components. J Exp Med 144: 1227–1242PubMedGoogle Scholar
  93. Weisbart RH, Kacena A, Schuh A, Golde DW (1988) GM–CSF induces human neutrophil-mediated phagocytosis by an Ig A Fc receptor activation mechanism. Nature 332: 647–648PubMedGoogle Scholar
  94. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–376PubMedGoogle Scholar
  95. Welsh JK, May JT (1979) Anti-infective properties of breast milk. J Pediatr 94: 1–9PubMedGoogle Scholar
  96. Williams RC, Gibbons RJ (1972) Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 177: 697–699PubMedGoogle Scholar
  97. Wilton JMA (1978) Suppression by Ig A of IgG–mediated phagocytosis by human polymorphonuclear leucocytes. Clin Exp Immunol 34: 423–428PubMedGoogle Scholar
  98. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T, Svanborg-Eden C (1990) Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 58: 3073–3077PubMedGoogle Scholar
  99. Wolf HM, Fischer MB, Pühringer H, Samstag A, Vogel E, Eibl MM (1994a) Human serum Ig A down-regulates the release of inflammatory cytokines (TNF-alpha, IL-6) in human monocytes. Blood 83: 1278–1288PubMedGoogle Scholar
  100. Wolf HM, Vogel E, Fischer MB, Rengs H, Schwarz HP, Eibl MM (1994b) Inhibition of receptor–dependent and receptor-independent generation of the respiratory burst in human neutrophils and monocytes by human serum Ig A. Pediatr Res 36: 1–8Google Scholar
  101. Wright SD, Levin SM, Jong MTC, Chad Z, Kabbash LG (1989) CR3 (CDllb/CD18) expresses one binding site for Arg-Gly-Asp containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 169: 175–183PubMedGoogle Scholar
  102. Yeaman GR, Kerr MA (1987) Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leukocytes. Clin Exp Immunol 68: 200–208PubMedGoogle Scholar
  103. Yodoi J, Adachi M, Teshigawara K, Miyama–Inaba M, Masuda T, Fridman WH (1983) T cell hybridomas co-expressing Fc–receptors (FcR) for different isotypes. II. IgA–induced formation of suppressive IgA binding factor(s) by a murine T hybridome bearing FcyR and FcaR. J Immunol 131: 303–310Google Scholar
  104. Yoshioka H, Iseki K, Fujita K (1983) Development and differences of intestinal flora in the neonatal period in breastfed and bottle-fed infants. Pediatrics 72: 317–321PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • M. M. Eibl
  • H. M. Wolf

There are no affiliations available

Personalised recommendations